Investigation of the monocyte/high-density lipoprotein ratio as a prognostic criterion in burn patients.
C-reactive protein
burn injuries
high-density lipoprotein
monocyte
monocyte/high-density lipoprotein
Journal
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
ISSN: 1524-475X
Titre abrégé: Wound Repair Regen
Pays: United States
ID NLM: 9310939
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
revised:
18
11
2022
received:
28
07
2022
accepted:
03
01
2023
pubmed:
13
1
2023
medline:
15
3
2023
entrez:
12
1
2023
Statut:
ppublish
Résumé
In this study, it was aimed to investigate the monocyte/high-density lipoprotein ratio as a prognostic criterion in adult burn patients. A descriptive and cross-sectional method was adopted in this study. The sample included 177 patients with burn injuries. This study was conducted in a research and training hospital in Turkey. Data were collected by the researchers in the burn unit. Descriptive methods, Kruskal-Wallis, Mann-Whitney U, ROC curve, and correlation analyses were used for the statistical analyses of the data. While 66.1% of the patients were second-degree burn patients, 96.6% of all patients recovered and were discharged from the hospital, and the rest died. In this study, the monocyte/high-density lipoprotein ratios of the patients decreased as their clinical condition worsened. The mean C-reactive protein value of the patients was 8.52 ± 5.02 on the 7th day. A statistically significant correlation was found between an increase in monocyte counts and a decrease in high-density lipoprotein concentrations at the 24th hour, 3rd day and 7th day after the burn (p < 0.01). The monocyte/high-density lipoprotein ratio can be considered a biomarker in the identification and follow-up of sepsis and morbidity durations in burn patients. A low monocyte/high-density lipoprotein ratio in burn patients can provide an insight into the severity of sepsis.
Substances chimiques
Lipoproteins, HDL
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-239Informations de copyright
© 2023 The Wound Healing Society.
Références
Akkoç MF, Bülbüloğlu S, Özdemir M. The effects of lockdown measures due to COVID-19 pandemic on burn cases. Int Wound J. 2021;18:367-374. doi:10.1111/iwj.13539
Akkoç MF, Bülbüloğlu S. Investigation of red cell distribution width as a prognostic criterion in severe burns. Int Wound J. 2021;19:1-10. doi:10.1111/iwj.13736
Schmid DM. The National Law Review: burn injuries: statistics, classifications, & causes. Stark & Stark Personal Injury Law. Accessed May 25, 2020. https://www.natlawreview.com/article/burn-injuriesstatistics-classifications-causes
World Health Organization. Burns. Accessed May 25, 2020. http://www.who.int/mediacentre/factsheets/fs365/en/
American Burn Association. National Burn Repository: Report of Data from 2008-2017. American Burn Association NBR Advisory Committee; 2017.
Sauaia A, Moore EE. Multiple Organ Failure. In: Vincent JL, Hall JB, eds. Encyclopedia of Intensive Care Medicine. Springer; 2012. doi:10.1007/978-3-642-00418-6_449
Ramírez M. Multiple organ dysfunction syndrome. Curr Probl Pediatr Adolesc Health Care. 2013;43(10):273-277. doi:10.1016/j.cppeds.2013.10.003
Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care J. 2010;14(5):R188. doi:10.1186/cc9300
Seada AIA, Younis GAE. Identification of predisposing factors to multiple organ dysfunctions syndrome among burned patients in intensive care unit at Mansoura University. Int Acad J Health Med Nurs. 2020;2(1):12-25.
Fitzwater J, Purdue GF, Hunt JL, O'Keefe GE. The risk factors and time course of sepsis and organ dysfunction after burn trauma. J Trauma. 2003;54(5):959-966.
Kallinen O, Maisniemi K, Böhling T, Tukiainen E, Koljonen V. Multiple organ failure as a cause of death in patients with severe burns. J Burn Care Res. 2012;33(2):206-211. doi:10.1097/bcr.0b013e3182331e73
Angus DC, Van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840-851.
Engel C, Brunkhorst FM, Bone HG, et al. Epidemiology of sepsis in Germany. Results from a national prospective multicenter study. Intensive Care Med. 2007;33:606-618.
Barker G, Leeuwenburgh C, Brusko T, Moldawer L, Reddy S, Guirgis F. Lipid and lipoprotein dysregulation in sepsis: clinical and mechanistic insights into chronic critical illness. J Clin Med. 2021;11:82.
van Leeuwen HJ, Heezius ECJM, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med. 2003;31:1359-1366.
Guirgis FW, Dodani S, Moldawer L, et al. Exploring the predictive ability of dysfunctional high-density lipoprotein for adverse outcomes in emergency department patients with sepsis: a preliminary investigation. Shock. 2017;48:539-544.
Grion CMC, Cardoso LTQ, Perazolo TF, et al. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients. Eur J Clin Invest. 2010;40:330-338.
Morin EE, Guo L, Schwendeman A, Li XA. HDL in sepsis - risk factor and therapeutic approach. Front Pharmacol. 2015;6:244.
Lee SH, Park MS, Park BH, et al. Prognostic implications of serum lipid metabolism over time during sepsis. Biomed Res Int. 2015;789298.
Guirgis FW, Donnelly JP, Dodani S, et al. Cholesterol levels and long-term rates of community-acquired sepsis. Crit Care. 2016;20:408.
Ansell BJ, Navab M, Hama S, et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003;108(22):2751-2756.
Al-Banna N, Lehmann C. Oxidized LDL and LOX-1 in experimental sepsis. Mediators Inflamm. 2013;2013:761789.
Guirgis FW, Dodani S, Leeuwenburgh C, et al. HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock. PLoS One. 2018;13:e0203813.
Libby P. Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045-2051.
Kanbay M, Solak Y, Unal HU. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol. 2014;46(8):1619-1625.
Yılmaz M, Kayancicek H. A new inflammatory marker: elevated monocyte to HDL cholesterol ratio associated with sming. J Clin Med. 2018;7(4):76.
Wasiak J, Lee SJ, Paul E, et al. Predictors of health status and health-related quality of life 12 months after severe burn. Burns. 2014;40(4):568-574.
Jeschke MG, Chinkes DL, Finnerty CC, et al. Pathophysiologic response to severe burn injury. Ann Surg. 2008;248(3):387-401.
Sierra R, Rello J, Bailen MA, et al. C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome. Intensive Care Med. 2004;30(11):2038-2045.
Gauglitz GG, Song J, Herndon DN, et al. Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock. 2008;30(5):503-507.
Lemstra AW, Kalisvaart KJ, Vreeswijk R, Van Gool WA, Eikelenboom P. Pre-operative inflammatory markers and the risk of postoperative delirium in elderly patients. Int J Geriatr Psychiatry. 2008;23(9):943-948.
Zahorec R. Ratio of neutrophil to lymphocyte counts - rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14.
Putra ON, Saputro ID, Nurrahman ND, Herawati ED, Dewi LK. Effects of empirical antibiotic administration on the level of C-reactive protein and inflammatory markers in severe burn patients. Ann Burns Fire Disasters. 2020;33(1):20-26.
Wang G, Xia Z. Monocyte subsets and their differentiation tendency after burn injury. Front Med. 2013;7(4):397-400.